Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-30 @ 1:12 AM
Study NCT ID:
NCT07322003
Status:
RECRUITING
Last Update Posted:
2026-02-27
First Post:
2026-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Sponsor:
Prilenia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-05
First Submit QC Date:
None
Study First Post Date:
2026-01-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-25
Last Update Post Date:
2026-02-27
Last Update Post Date Type:
ACTUAL